Jian Ping Chai

Intravenous therapy is the standard medical procedure that is used for administering medications directly into the vein. The automated drug infusion devices are designed in such a way that they provide exact medication doses with safety measures included. On the other hand, this is why they must be regularly watched by healthcare providers. This paper introduces a cloud-based IoT drug infusion system that was developed to address remote patient care needs. This system enables remote, accurate, and secure management of medication delivery. Its key contributions include allowing healthcare providers to control and monitor IV infusions remotely while maintaining safety features. The system consists of a microcontroller that is responsible for data processing, a control system that oversees infusion rate regulation, and an IoT-based framework that allows for remote monitoring and alerts via a user-friendly web interface. This new approach to care will therefore improve patient care by providing remote management of medications.

Technological advancements are propelling medical technology towards automation through the application and widespread use of automatic control, sensing, and Internet of Things (IoT) technologies. Currently, IoT technology has been extensively applied in medical devices, aiming to ensure patient safety through more real-time detection and more effective management. In the monitoring of intravenous infusion, accurately sensing the infusion conditions in real time is particularly important. This article introduces a low-cost smart infusion device based on IoT technology, which controls the infusion rate with a peristaltic pump and monitors the volume of fluid delivered. It uses an improved, self-calibrating weighing sensor to achieve the real-time closed-loop control of the flow rate, ensuring patient safety. Additionally, the Blynk dashboard can be used for monitoring and controlling the flow rate and infusion volume.

This comprehensive study presents a pioneering approach to limb lengthening, leveraging the advancements in wireless technology to enhance orthopedic healthcare. Historically, limb lengthening has been a response to discrepancies caused by fractures, diseases, or congenital defects, utilizing the body’s innate ability to regenerate bone and surrounding tissues. Traditionally, this involved external or internal fixation devices, such as the Ilizarov and Taylor Spatial frames or the Precice nail and Fitbone. The focal point of this research is the development and testing of a wireless intramedullary nail implant prototype, controlled remotely via a mobile application. This implant comprises a microcontroller, Bluetooth Low Energy module, a brushed DC motor controlled through an H-bridge, and a force sensor, all powered by medical-grade batteries. The integration of wireless technology facilitates patient autonomy in managing limb lengthening, reducing the need for frequent clinical visits. The methodology involves a detailed block diagram for our proposed work, outlining the process from treatment planning to the initiation of limb lengthening via the mobile application. Osteogenesis, the formation of new bone tissue, plays a crucial role in this procedure, which includes pre-surgery assessment, osteotomy, latency, distraction, consolidation, and removal phases. Key challenges addressed include custom battery design for efficient operation, size constraints, and overcoming signal interference due to the Faraday cage effect. Attenuation testing, simulating human tissue interaction, validates the implant’s connectivity. In conclusion, this research marks a significant stride in orthopedic care, demonstrating the feasibility of a wireless implant for limb lengthening. It highlights the potential benefits of reduced clinical visits, cost efficiency, and patient convenience. Despite limitations such as battery requirements and signal interference, this study opens avenues for future enhancements in patient-centered orthopedic treatments, signaling a transformative shift in managing limb length discrepancies.

In the present day, IoT technology is widely applied in the field of medical devices to facilitate real-time monitoring and management by medical staff, thereby better-ensuring patient safety. In IoT intravenous infusion monitoring sensors, it is particularly important to ensure that air bubbles are not infused into the patient’s body. The most common method for bubble detection during intravenous infusions is the use of infrared or laser sensors, which can usually meet design requirements at a relatively low cost. Another method is the use of ultrasonic detection of bubbles, which achieves high accuracy but has not been widely promoted in the market due to higher costs. This proposed work introduces a new type of sensor that detects bubbles by monitoring changes in capacitance between two electrodes installed at the surface of the infusion pipe. If this sensor is deployed on the ESP32 platform, which is widely used in embedded IoT devices, it can achieve 35 μL bubble detection precision with an average power consumption of 5.18 mW and a mass production cost of $0.022. Although the precision of this sensor is significantly lower than the low-cost IR bubble sensor, it still satisfies the design requirement of the IV infusion IoT sensor.